Laura R Prakash

8PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisNeurology and neuromuscular diseasesDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2026
Technical Aspects of Pancreatectomy in the Alliance A021501 Multicenter Clinical Trial of Neoadjuvant Therapy for Pancreatic Cancer: Surgical and Pathologic Documentation.

|Feb 26, 2026
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor.

Jin Guo, Kever A Lewis, Laura Prakash

|Jan 15, 2026
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma.

Adriana C Gamboa, Kever A Lewis, Laura R Prakash

|Oct 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series.

Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef

|Oct 16, 2024
The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.

Mehran Taherian, Matthew H G Katz, Laura R Prakash

|Apr 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.

Chirayu Mohindroo, Seyda Baydogan, Parul Agarwal

Pageof 2

Frequent Collaborators

5 joint publications

Ching-Wei D Tzeng

3 joint publications

Dan Zhao

3 joint publications

Matthew H G Katz

2 joint publications

Huamin Wang